Mitsui Chemicals (4183) AI Stock Analysis

• Market Cap: ¥930.53B
• Dividend Yield: 3.82%
• Average Volume (3M): 752.31K
• Price to Earnings (P/E): 52.4
• Beta (1Y): 1.17
• Revenue Growth: -4.63%
• EPS Growth: -65.11%
• Country: JP
• Employees: 19,861
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 39.19
• Shares Outstanding: 401,687,620
• 10 Day Avg. Volume: 656,460
• 30 Day Avg. Volume: 752,313
• PEG Ratio: -0.56
• Price to Book (P/B): 0.74
• Price to Sales (P/S): 0.35
• P/FCF Ratio: 10.17
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥2,716.25
• Price Target Upside: 32.79% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 8
• EPS Forecast (FY): 133.27
• Revenue Forecast (FY): ¥1.68T

• Rating: 61 Neutral
• Price Target: ¥2,473.00 ▲(20.90% Upside)
• Action: Reiterated Date: 02/07/26
• Date: Action: Reiterated 02/07/26

The score is driven primarily by pressured financial performance (weak TTM revenue and very thin profitability with volatile free cash flow) and a demanding valuation (high P/E). These are partially offset by strong technical momentum with price above key moving averages and positive MACD.

Positive Factors

Diversified specialty portfolio

Mitsui Chemicals serves multiple end markets (automotive, packaging, electronics, healthcare, industrial) and sells both commodity building blocks and higher value-added functional materials. This product and end-market diversity lowers exposure to a single cycle and supports durable revenue streams through technical service, long qualification cycles, and embedded customer relationships.

Manageable leverage

Debt-to-equity near 0.84–0.94 indicates a reasonable balance sheet structure that preserves financial flexibility. Manageable leverage supports capacity to fund capex, sustain operations during cyclical dips, and maintain strategic investments without forcing distressed asset sales, making capital structure a durable strength over coming months.

Solid operating cash flow

Consistent operating cash flow (TTM ~¥200B) shows the core business generates real cash even as earnings have fluctuated. Reliable OCF supports reinvestment in specialty product development, working capital needs, and debt servicing, providing a stable cash-generation base that matters for 2–6 month strategic planning.

Negative Factors

Declining revenue trend

Trailing revenue decline (-2.5% TTM) and negative recent growth indicate weaker demand or pricing pressure in key segments. Reduced top-line scale can compress operating leverage, limit reinvestment capacity, and make margin recovery harder—risks that are structural if market conditions or product mix do not improve over the next several quarters.

Thin net margins and collapsed ROE

Net margin near 1% and ROE around 2% reflect substantially diminished profitability versus prior years. Persistently low returns weaken the company's ability to self-fund growth, attract capital, and justify long-term investments; restoring pricing power or structural cost efficiencies is necessary for durable improvement.

Volatile and weakened free cash flow

Inconsistent free cash flow and a ~-20% TTM decline indicate weaker cash conversion and higher reinvestment or working capital needs. Volatile FCF constrains the ability to reduce debt, sustain dividends, or fund strategic R&D/expansion—creating a medium-term funding risk if the company cannot stabilize cash generation.

Mitsui Chemicals Business Overview & Revenue Model

Company Description

Mitsui Chemicals, Inc. engages in the mobility, health care, food and packaging, basic materials, and other businesses. The company's Mobility segment develops elastomers, performance compounds, functional polymers, polypropylene compounds, and performance polymers; and offers services related to the development of automotive and industrial products. Its Health Care segment offers vision care materials, nonwoven fabrics, dental materials, and personal care materials. The Food & Packaging segment provides coating and engineering materials, performance films and sheets, and agrochemical products. The Basic Materials segment provides ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid, PET, polyurethane materials, and industrial chemical products. The company also offers civil engineering and construction materials; cosmetics; wood adhesives, paper resins, foliar activator, and other chemical products; polyolefin, urethanes, and synthetic resins and resin films; injection molds and presses; phosphoric acid and fertilizers; spunbonded nonwoven fabrics and synthetic fibers; monomers for optical lenses; and fine chemical products and inorganic chemicals. In addition, it is involved in performance analysis, physical property measurements, and safety tests on chemicals; and placements, temporary works, and insurance and travel services, and consignments, as well as the sale of electronics and information materials. The company sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Mitsui Chemicals generates revenue through multiple streams, primarily from the sale of its chemical and polymer products to various industries. The company focuses on high-value-added products, which tend to offer better margins. Key revenue streams include functional chemicals, such as adhesives and coatings, performance materials like engineering plastics and films, and agricultural chemicals. Mitsui Chemicals also engages in strategic partnerships and joint ventures with other companies to enhance its market reach and develop new technologies. Additionally, the company invests in research and development to innovate and improve its product offerings, which contributes to its competitive advantage and overall earnings.

Mitsui Chemicals Financial Statement Overview

Summary

Financials are mixed: TTM revenue declined (-2.5%) and net margin is thin (~1%), showing pressured earnings versus FY2022–FY2023. The balance sheet is reasonably structured with manageable leverage (debt-to-equity ~0.84–0.94), but ROE has fallen sharply (TTM ~2%). Operating cash flow is solid, yet free cash flow is volatile and recently weakened (TTM FCF growth ~-20%), indicating weaker cash conversion.

Income Statement

TTM (Trailing-Twelve-Months) revenue declined (-2.5%) and profitability is currently thin (about 1.0% net margin), indicating a weaker earnings environment versus prior years. While gross margin is relatively steady around the low-20% range and EBITDA margin remains near ~9–13% historically, net income has compressed materially from the stronger FY2022–FY2023 period (when net margins were meaningfully higher). Overall, the income statement shows acceptable operating profitability but elevated earnings volatility and a weaker recent demand/pricing backdrop.

Balance Sheet

Leverage appears manageable with debt-to-equity consistently around ~0.84–0.94, supported by a sizable equity base. That said, returns on equity have fallen sharply in the most recent periods (TTM around ~2% versus double-digit levels in FY2022–FY2023), signaling that the balance sheet is not currently generating strong shareholder returns. In short: balance sheet structure is reasonable, but profitability deterioration increases risk if conditions remain soft.

Cash Flow

Operating cash flow is solid and improved versus some prior years (TTM roughly ¥200B), but free cash flow has been inconsistent, including negative free cash flow in FY2022–FY2023 and a TTM decline (free cash flow growth about -20%). Cash conversion looks weaker in the latest period, with free cash flow only modestly exceeding net income (roughly ~0.33x), suggesting heavier reinvestment/capex needs and less cash retained for debt reduction or shareholder returns.

Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	1.69T	1.81T	1.75T	1.88T	1.61T	1.21T
Gross Profit	372.42B	388.29B	370.80B	381.49B	378.74B	293.84B
EBITDA	159.25B	186.12B	183.24B	197.27B	204.58B	150.44B
Net Income	17.11B	32.24B	50.00B	82.94B	109.99B	57.87B
Balance Sheet
Total Assets	2.21T	2.15T	2.22T	2.07T	1.93T	1.56T
Cash, Cash Equivalents and Short-Term Investments	192.23B	209.23B	210.29B	186.31B	181.15B	195.99B
Total Debt	758.45B	737.98B	756.76B	738.25B	666.09B	510.22B
Total Liabilities	1.20T	1.18T	1.23T	1.18T	1.13T	875.97B
Stockholders Equity	877.42B	848.28B	862.85B	786.83B	712.65B	607.92B
Cash Flow
Free Cash Flow	66.11B	62.09B	7.35B	-36.62B	-23.63B	97.74B
Operating Cash Flow	200.11B	200.50B	161.34B	101.24B	92.58B	174.32B
Investing Cash Flow	-183.59B	-165.01B	-123.94B	-106.34B	-205.23B	-77.56B
Financing Cash Flow	-12.53B	-74.44B	-26.02B	2.54B	89.22B	-68.96B

Mitsui Chemicals Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2045.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4183, the sentiment is Positive. The current price of 2045.5 is below the 20-day moving average (MA) of 2330.37, below the 50-day MA of 2178.77, and above the 200-day MA of 1854.68, indicating a neutral trend. The MACD of 36.75 indicates Positive momentum. The RSI at 55.13 is Neutral, neither overbought nor oversold. The STOCH value of 36.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4183.

Mitsui Chemicals Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4202	80 Outperform	¥435.63B	10.54	9.34%	4.27%	-0.48%	-35.29%
4118	74 Outperform	$333.84B	12.62	5.47%	3.41%	2.60%	9.50%
4631	65 Neutral	¥419.23B	12.96	8.14%	2.61%	-1.45%	―
5201	64 Neutral	¥1.47T	21.24	3.63%	3.98%	-1.17%	―
4182	64 Neutral	¥846.59B	-52.21	-1.15%	3.49%	-6.83%	-123.67%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
4183	61 Neutral	¥930.53B	52.39	2.02%	3.82%	-4.63%	-65.11%

Mitsui Chemicals Corporate Events

Mitsui Chemicals to Launch Corporate Fellow System After Ending Advisor Roles

Mitsui Chemicals will introduce a new Corporate Fellow system from April 1, 2026, following its earlier decision to abolish the Senior Advisor and Advisor system as of March 31, 2025 to improve management transparency and effectiveness. Under the new framework, former directors and executives may be appointed as Corporate Fellows to undertake external activities—such as holding key roles in economic and industry organizations closely linked to the company—on an unpaid, part-time, fixed-term basis, with appointments and dismissals decided by the Board of Directors based on recommendations from a nomination committee dominated by independent outside directors. While Corporate Fellows will not participate in the company’s management or corporate governance, the system is intended to leverage retirees’ expertise and networks to enhance Mitsui Chemicals’ corporate value and external presence without compromising governance reforms.

The most recent analyst rating on (JP:4183) stock is a Hold with a Yen2422.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Names New CEO and Boosts Outside Directors in Governance Overhaul

Mitsui Chemicals has announced a leadership reshuffle effective April 1, 2026, appointing current President & CEO Osamu Hashimoto as Representative Director and Chairman, while elevating Satoshi Ichimura from Managing Executive Officer and board member to Representative Director, President & CEO, in a move aimed at accelerating execution of its VISION 2030 strategy and driving sustainable growth. The company is simultaneously overhauling its board and audit structure, increasing the number of outside directors so that external board and audit members will constitute half of the total following the June 2026 shareholders’ meeting, a governance reform intended to strengthen oversight and align the organisation with global standards, while bringing in new managing executive officers to the board and planning the retirement of some long-serving directors.

The most recent analyst rating on (JP:4183) stock is a Hold with a Yen2422.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Launches ¥30 Billion Share Buyback and Treasury Share Cancellation

Mitsui Chemicals’ board has approved a share buyback of up to 18.4 million common shares, representing about 4.9% of shares outstanding (excluding treasury shares), for a total of up to ¥30 billion, to be conducted through market purchases from February 6 to July 31, 2026. Following this repurchase, the company plans to cancel a portion of its treasury shares so that holdings will be reduced to approximately 5% of total shares in issue as of August 31, 2026, a move aimed at improving capital efficiency and reinforcing shareholder returns by reducing share count and potentially supporting earnings per share and return metrics over time.

The most recent analyst rating on (JP:4183) stock is a Hold with a Yen2422.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Unveils 3Q FY2025 Results and Full-Year Outlook

Mitsui Chemicals has released its financial summary for the third quarter of fiscal 2025 and provided an updated outlook for the full year ending March 31, 2026. The document outlines consolidated financial highlights, cash flow trends and segment-level performance, including operating income before special items, as well as the impact of temporary factors and restructuring benefits in its Basic & Green Materials business. It also details major investment projects, non-recurring items and planned shareholder returns, giving investors and stakeholders a structured view of how each business segment is contributing to earnings and how the company expects its financial position and profitability to evolve over the remainder of the fiscal year.

The most recent analyst rating on (JP:4183) stock is a Hold with a Yen2422.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Q3 FY2025 Profit Softens on Lower Sales, Maintains Outlook and Dividend After Stock Split

Mitsui Chemicals reported a decline in consolidated sales revenue to ¥1,218.7 billion for the third quarter of FY2025 from ¥1,338.8 billion a year earlier, as lower volumes and prices—particularly in Basic & Green Materials and Mobility Solutions—weighed on the top line. Operating income before special items also fell to ¥68.0 billion from ¥75.8 billion, though full-year operating income before special items is still forecast to edge up to ¥103.0 billion, reflecting expected improvement in higher-margin businesses such as ICT Solutions. Despite weaker revenue, the balance sheet remained solid, with total assets increasing to ¥2,209.1 billion and equity attributable to owners rising, while free cash flow turned negative in the quarter due to higher investment and financing outflows. The company executed a two-for-one stock split on January 1, 2026 and maintained its dividend policy in split-adjusted terms, signaling a continued focus on shareholder returns even as it navigates challenging market conditions in feedstock prices and key end markets.

The most recent analyst rating on (JP:4183) stock is a Hold with a Yen2422.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Announces Stock Split and Dividend Revision

Mitsui Chemicals, Inc. announced a two-for-one stock split to make its shares more affordable and expand its investor base. The company also revised its dividend forecast in line with the stock split, although there is no effective change from the previous forecast, indicating a strategic move to maintain shareholder value.

The most recent analyst rating on (JP:4183) stock is a Hold with a Yen3812.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Reports Decline in First Half FY2025 Financial Results

Mitsui Chemicals reported a decline in sales revenue and operating income for the first half of FY2025 compared to the previous year. The company has undergone organizational reforms and segment revisions, impacting its financial performance. Despite the challenges, certain segments like ICT solutions showed growth, while others like basic & green materials experienced significant declines. The company also announced a two-for-one stock split, affecting dividend forecasts.

The most recent analyst rating on (JP:4183) stock is a Hold with a Yen3812.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.